APA (7th ed.) Citation

R, L., BA, F., L, P., K, H., & C, H. (2024). Long-Term Survival in Human Epidermal Growth Factor Receptor 2-Positive Bone-Only Metastatic Breast Cancer: Trastuzumab, Denosumab, and Potential Synergistic Effects. Cureus, 16(9), e68576. https://doi.org/10.7759/cureus.68576

Chicago Style (17th ed.) Citation

R, Ladak, Fifield BA, Porter L, Hirmiz K, and Hamm C. "Long-Term Survival in Human Epidermal Growth Factor Receptor 2-Positive Bone-Only Metastatic Breast Cancer: Trastuzumab, Denosumab, and Potential Synergistic Effects." Cureus 16, no. 9 (2024): e68576. https://doi.org/10.7759/cureus.68576.

MLA (9th ed.) Citation

R, Ladak, et al. "Long-Term Survival in Human Epidermal Growth Factor Receptor 2-Positive Bone-Only Metastatic Breast Cancer: Trastuzumab, Denosumab, and Potential Synergistic Effects." Cureus, vol. 16, no. 9, 2024, p. e68576, https://doi.org/10.7759/cureus.68576.